KRS 214.017: Caregiver of individual with diabetes may administer or assist with self -

administration of diabetes medications if the caregiver is appropriately trained

and has the written authorization of the individual's health care practitioner.

(1) The caregiver of an individual who has diabetes may administer or assist with the

self-administration of the medication listed under subsection (2) of this section if

the caregiver:

(a) Has been trained to administer insulin and glucagon, recognize the signs and

symptoms of hypoglycemia and hyperglycemia, and take appropriate steps to

respond to these symptoms by:

1. A physician who is licensed under the provisions of KRS Chapter 311;

2. An advanced practice registered nurse, registered nurse, or licensed

practical nurs e who is licensed under the provisions of KRS Chapter

314; or

3. Any other health care professional with diabetes treatment within his or

her scope of practice; and

(b) Has the written authorization of the health care practitioner for an individual

who has diabetes. The written authorization shall contain the following

information:

1. The individual's name;

2. The name and purpose of the medication;

3. The prescribed dosage;

4. The route of administration;

5. The frequency with which the medication may be administered; and

6. The circumstances under which the medication may be administered.

(2) A caregiver of an individual who has diabetes who meets the criteria under

subsection (1) of this section may administer or assist with the self -administration

of:

(a) Glucagon subcutaneously, to individuals with diabetes who are experiencing

hypoglycemia or other conditions noted in the health care practitioner's written

statement under subsection (1)(b) of this section; and

(b) Insulin subcutaneously, through the i nsulin delivery method used by the

individual and at the times and under the conditions noted in the health care

practitioner's written statement under subsection (1)(b) of this section.

(3) The written authorization required under subsection (1)(b) of thi s section shall be

kept on file by the authorizing health care practitioner.

(4) The health care practitioner or the caregiver shall inform the individual who has

diabetes or the individual's guardian that the health care practitioner, the caregiver,

or his or her employer shall not incur any liability as a result of any injury sustained

by the individual from any reaction to any medication listed under subsection (2) of

this section to treat a hypoglycemic or hyperglycemic episode or its administration,

unless the injury is the result of negligence or misconduct on behalf of the health

care practitioner, the caregiver, or his or her employer. The individual or guardian

of the individual shall sign a written statement acknowledging that the health care

practitioner, the caregiver, or his or her employer shall incur no liability except as

provided in this subsection, and the individual or guardian of the individual shall

hold harmless the health care practitioner, the caregiver, or his or her employer

against any claims made for any reaction to any medication listed under subsection

(2) of this section to treat a hypoglycemic or hyperglycemic episode or its

administration if the reaction is not due to negligence or misconduct on behalf of

the health care practitioner, the caregiver, or his or her employer.

(5) Notwithstanding any other provision of the law to the contrary:

(a) The administration of the medications listed under subsection (2) of this

section by an authorized caregiver shall not constitute the pra ctice of nursing

and shall be exempt from all applicable statutory and regulatory provisions

that restrict the activities that may be delegated to or performed by a person

who is not a licensed health care professional; and

(b) A licensed health care profe ssional may provide training to or supervise a

caregiver in the administration of the medications listed under subsection (2)

of this section.